| Darryl Kunihiro, | |
|
3430 E La Palma Ave, Anaheim, CA 92806-2020 | |
| (714) 644-7180 | |
| Not Available |
| Full Name | Darryl Kunihiro |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3430 E La Palma Ave, Anaheim, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649718651 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 55999 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darryl Kunihiro, 3430 E La Palma Ave, Anaheim, CA 92806-2020 Ph: () - | Darryl Kunihiro, 3430 E La Palma Ave, Anaheim, CA 92806-2020 Ph: (714) 644-7180 |
News Archive
As support for funds for mental ailments mounts, a coalition of mental health experts are lobbying for greater support for mental health services for children. The coalition comprises The Royal Australian and New Zealand College of Psychiatrists; the Australian Psychological Society; NIFTeY (National Investment for the Early Years); the Australian Infant, Child, Adolescent and Family Mental Health Association; the Australian Association of Infant Mental Health, and the Australian Child and Adolescent Trauma, Loss and Grief Network.
An international trial looking at the benefits of giving blood-pressure lowering medication to elderly patients has stopped early, after researchers observed significant reductions in overall mortality in those receiving treatment.
Shark feeding habits are helping scientists identify marks on human bones found in the ocean. By analyzing shark scavenging behavior, the University of Florida's C.A. Pound Human Identification Laboratory identified which marks were left behind by sharks, what species of sharks made the marks and where the feedings might have occurred.
Bayer today announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor, which demonstrated that treatment with regorafenib resulted in a 31 percent partial response rate and 50 percent stabilization rate in patients with metastatic renal cell carcinoma (RCC).
› Verified 8 days ago
Tarjani Lalitkumar Padmani, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 735 S Dove Tree Ln, Anaheim, CA 92808 Phone: 714-280-0825 | |
John Wang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 88 E Orangethorpe Ave, Anaheim, CA 92801 Phone: 714-626-0014 | |
Mohamed Hussein, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1807 W Katella Ave Ste 206, Anaheim, CA 92804 Phone: 714-733-7978 Fax: 714-733-7969 | |
Kasey Kim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 E Lincoln Ave Ste B, Anaheim, CA 92805 Phone: 714-776-1020 Fax: 714-776-7053 | |
Dr. Lan-phuong Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 N Lakeview Ave, Kaiser Permanente Anticoagulation Service, Anaheim, CA 92807 Phone: 714-279-5403 Fax: 714-279-4809 | |
Hanny M Tadros, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 S Brookhurst St, Anaheim, CA 92804 Phone: 714-778-3123 | |
Atoussa Najafian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 440 N Euclid St, Anaheim, CA 92801 Phone: 714-491-1778 |